Nuveen’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-325,552
| Closed | -$6.04M | – | 3399 |
|
|
2023
Q3 | $6.04M | Sell |
325,552
-107,194
| -25% | -$1.21M | ﹤0.01% | 1768 |
|
|
2023
Q2 | $4.79M | Sell |
432,746
-382,702
| -47% | -$5.33M | ﹤0.01% | 1942 |
|
|
2023
Q1 | $11M | Buy |
815,448
+17,538
| +2% | +$303K | ﹤0.01% | 1424 |
|
|
2022
Q4 | $9.87M | Buy |
797,910
+385,884
| +94% | +$5.46M | ﹤0.01% | 1497 |
|
|
2022
Q3 | $5.75M | Buy |
412,026
+94,515
| +30% | +$1.52M | ﹤0.01% | 1822 |
|
|
2022
Q2 | $4.38M | Buy |
317,511
+194,584
| +158% | +$3.12M | ﹤0.01% | 2032 |
|
|
2022
Q1 | $2.02M | Buy |
122,927
+42,851
| +54% | +$671K | ﹤0.01% | 2500 |
|
|
2021
Q4 | $1.1M | Sell |
80,076
-7,916
| -9% | -$133K | ﹤0.01% | 2828 |
|
|
2021
Q3 | $1.4M | Sell |
87,992
-5,933
| -6% | -$94.9K | ﹤0.01% | 2837 |
|
|
2021
Q2 | $1.88M | Sell |
93,925
-2,884
| -3% | -$57.2K | ﹤0.01% | 2747 |
|
|
2021
Q1 | $2.23M | Sell |
96,809
-583
| -0.6% | -$16.3K | ﹤0.01% | 2566 |
|
|
2020
Q4 | $2.4M | Sell |
97,392
-124,393
| -56% | -$4.12M | ﹤0.01% | 2415 |
|
|
2020
Q3 | $9.2M | Buy |
221,785
+117,740
| +113% | +$5.41M | ﹤0.01% | 1574 |
|
|
2020
Q2 | $4.99M | Sell |
104,045
-938
| -0.9% | -$72.5K | ﹤0.01% | 1900 |
|
|
2020
Q1 | $6.61M | Sell |
104,983
-7,502
| -7% | -$674K | ﹤0.01% | 1546 |
|
|
2019
Q4 | $13.9M | Sell |
112,485
-1,542
| -1% | -$138K | 0.01% | 1385 |
|
|
2019
Q3 | $7.57M | Sell |
114,027
-6,864
| -6% | -$461K | ﹤0.01% | 1733 |
|
|
2019
Q2 | $9.62M | Buy |
120,891
+113,549
| +1,547% | +$10.2M | ﹤0.01% | 1637 |
|
|
2019
Q1 | $821K | Buy |
+7,342
| New | +$802K | ﹤0.01% | 770 |
|
|
2014
Q2 | – | Sell |
-5,151
| Closed | -$1.7M | – | 1663 |
|
|
2014
Q1 | $1.7M | Sell |
5,151
-1,053
| -17% | -$355K | 0.01% | 878 |
|
|
2013
Q4 | $424K | Buy |
+6,204
| New | +$359K | ﹤0.01% | 1352 |
|
Nuveen's ICPT Position: Q4 2023 in Review
Nuveen sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 325,552 shares — an estimated $6.04M sold.
Nuveen first reported a position in ICPT in Q4 2013 and held it in 21 quarters. The position peaked at $13.9M in Q4 2019. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- Nuveen reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Nuveen sold 325,552 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $6.04M.
- Nuveen first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2013 and held it in 21 quarters.
- Nuveen's Intercept Pharmaceuticals, Inc. position peaked at $13.9M in Q4 2019.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on Nuveen's 13F filing for Q4 2023, filed 14 Feb 2024.